Announcement • Apr 16
Free Flow, Inc. Auditor Raises 'Going Concern' Doubt Free Flow, Inc. filed its 10-K on Apr 14, 2025 for the period ending Dec 31, 2024. In this report its auditor, BCRG Group, gave an unqualified opinion expressing doubt that the company can continue as a going concern. Announcement • Apr 02
Free Flow, Inc. announced delayed annual 10-K filing On 04/01/2025, Free Flow, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Announcement • Aug 27
Free Flow, Inc. Appoints Ravinder Tikoo as Director and Chairman of the Board The board of directors of Free Flow, Inc. has appointed Ravinder Tikoo. M.D, a board-certified neurologist, as director and chairman of the board. FFLO’s chief executive officer, Mr. Sabir Saleem, and independent director, Mr. Shah Wali Khan, will remain on the board as directors and will work with Dr. Tikoo to oversee and guide the Company. After graduating with honors with a BS in Chemistry and Biochemistry from the University of Iowa, Dr. Tikoo continued his education there and received his medical degree in 1991. He completed an internship in general medicine at Northwestern University Medical Center, followed by a residency in neurology at the New York Hospital/Cornell Medical Center. Dr. Tikoo then completed a fellowship in neurology, also at Cornell Medical Center. From 1997 to 2001, Dr. Tikoo served as Assistant Neurology Attending/Instructor in Neurology for the New York University Medical Center, Department of Neurology, and from 2002 to 2017, he served as Assistant Clinical Professor at the New York Hospital/Weill Medical College of Cornell University in New York. Dr. Tikoo has also been in private practice in New Jersey since 2008.